Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal
AMDIncidencePT
2 other identifiers
observational
5,996
1 country
1
Brief Summary
To assess the five-year incidence of AMD in a population from the central region of Portugal, previously phenotypically characterized.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2016
CompletedFirst Posted
Study publicly available on registry
April 22, 2016
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2017
CompletedNovember 9, 2017
November 1, 2017
1.2 years
April 20, 2016
November 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phenotypic classification of AMD in the five-year clinical visit. Comparison of this classification with the grading of 5 years ago.
5 years
Secondary Outcomes (1)
Risk factors: Demographic, Medical history, Ophthalmologic history, Family history of AMD, Systemic comorbidities and medication, Nutritional and Lifestyle habits. Signs of AMD on the multimodal evaluation.
5 years
Eligibility Criteria
The study population will consist of male and female subjects who have participated and phenotyped in the Epidemiologic Coimbra Eye Study (NTC01298674). It is expected to recruit up to a total of 5.996 subjects, that is up to 2.975 subjects from the Mira Healthcare Unit and up to 3.021 subjects from the Lousã Healthcare Unit.
You may qualify if:
- Subjects who participated in the Epidemiologic Coimbra Eye Study (NCT01298674) and that were phenotyped;
- Subjects capable of understanding the information about the study and to give their informed consent to enter the study;
- Subjects willing and able to comply with the study procedures.
You may not qualify if:
- \- Not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AIBILI/CEC - Centro Ensaios Clínicos
Coimbra, 3000-548, Portugal
Related Publications (1)
Barreto P, Farinha C, Coimbra R, Cachulo ML, Melo JB, Lechanteur Y, Hoyng CB, Cunha-Vaz J, Silva R. Interaction between genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration. Coimbra Eye Study Report 8. Eye Vis (Lond). 2023 Aug 14;10(1):38. doi: 10.1186/s40662-023-00355-0.
PMID: 37580831DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rufino Silva, PhD
Association for Innovation and Biomedical Research on Light and Image
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2016
First Posted
April 22, 2016
Study Start
July 1, 2016
Primary Completion
September 18, 2017
Study Completion
October 31, 2017
Last Updated
November 9, 2017
Record last verified: 2017-11